Emerging Veterinary Toxins: Diagnosis & Treatment
About this Webinar
This course provides up‑to‑date training on four emerging toxins in veterinary medicine: oclacitinib, acrylamide, GLP‑1 receptor agonists, and 7‑hydroxymitragynine (a primary kratom alkaloid). You’ll learn how each toxin affects pets, where exposure commonly occurs, how to recognize clinical signs and current best practices for diagnosis and treatment.
What You’ll Learn
- New and emerging toxins that veterinary professionals are increasingly encountering- Gain essential knowledge about four toxins that are showing up more often in clinical practice and poison control consultations.
- Background and exposure risks for each toxin- Understand how pets may be exposed, the mechanisms of toxicity and the potential dangers each substance poses to dogs and cats.
- Diagnostic approach and treatment protocols- Learn practical strategies for identifying toxin exposure, interpreting clinical signs and choosing appropriate treatment options.
Takeaways
- Clear overview of oclacitinib, acrylamide, GLP‑1 and 7‑hydroxymitragynine as emerging veterinary toxicology concerns.
- Exposure sources, toxic effects and risk profiles for each toxin.
- Step‑by‑step guidance on diagnosis, treatment and clinical management to support better patient outcomes.
Suited For
This session is suited for veterinarians and veterinary staff.
Credits
This session is pending RACE approval.
Register now and you’ll be notified when the recording is available.
Kirsten Waratuke
DVM, DABT, Consulting Veterinarian in Clinical Toxicology, ASPCA Poison Control
Dr. Kirsten Waratuke serves as the Director of Veterinary Quality Assurance at ASPCA Poison Control. She earned both her undergraduate and Doctor of Veterinary Medicine degrees from the University of Illinois and is board-certified by the American Board of Toxicology and the American Board of Veterinary Toxicology.
